tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NVS Stock Latest News

REGN, GMAB, ARWR: Which Healthcare Stock Is Best Buy Ahead of U.S. Drug Approvals This Nov?
Market NewsREGN, GMAB, ARWR: Which Healthcare Stock Is Best Buy Ahead of U.S. Drug Approvals This Nov?
4d ago
NVS
ARWR
Novartis announces Phase III trial for KLU156 met primary endpoint
PremiumThe Fly
Novartis announces Phase III trial for KLU156 met primary endpoint
5d ago
NVS
Novartis Stock (NVS) Doesn’t Suck as it Hails Generational Anti-Malaria Drug
PremiumMarket News
Novartis Stock (NVS) Doesn’t Suck as it Hails Generational Anti-Malaria Drug
5d ago
NVS
Dyne Therapeutics price target lowered to $11 from $13 at Oppenheimer
PremiumThe Fly
Dyne Therapeutics price target lowered to $11 from $13 at Oppenheimer
6d ago
DYN
NVS
FDA appoints Richard Pazdur as Director of CDER
PremiumThe Fly
FDA appoints Richard Pazdur as Director of CDER
7d ago
AZN
BMY
Novartis opens radioligand therapy manufacturing facility in California
PremiumThe FlyNovartis opens radioligand therapy manufacturing facility in California
8d ago
NVS
Novartis Issues $6 Billion in Debt Securities to Bolster Financial Strategy
Premium
Company Announcements
Novartis Issues $6 Billion in Debt Securities to Bolster Financial Strategy
13d ago
6K
NVS
Cautious Hold on Novartis AG Amid Mixed Ianalumab Data and Valuation Concerns
Premium
Ratings
Cautious Hold on Novartis AG Amid Mixed Ianalumab Data and Valuation Concerns
15d ago
NVS
Novartis upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe Fly
Novartis upgraded to Overweight from Equal Weight at Morgan Stanley
18d ago
NVS
Positive Long-Term Growth Outlook for Novartis AG Amid Temporary Setbacks
PremiumRatings
Positive Long-Term Growth Outlook for Novartis AG Amid Temporary Setbacks
18d ago
NVS
FDA moves to accelerate biosimilar development, lower drug costs
PremiumThe Fly
FDA moves to accelerate biosimilar development, lower drug costs
19d ago
AZN
BMY
Novartis reports NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective
PremiumThe Fly
Novartis reports NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective
20d ago
NVS
Novartis AG Reports Strong Q3 2025 Earnings Growth
PremiumCompany AnnouncementsNovartis AG Reports Strong Q3 2025 Earnings Growth
20d ago
NVS
Novartis AG Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Novartis AG Earnings Call: Growth Amid Challenges
20d ago
NVS
Tourmaline Bio acquisition completed by Novartis
Premium
The Fly
Tourmaline Bio acquisition completed by Novartis
21d ago
NVS
TRML
Warner Bros. Discovery upgraded, F5 downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Warner Bros. Discovery upgraded, F5 downgraded: Wall Street’s top analyst calls
21d ago
DD
NVS
Novartis Reports Strong Q3 2025 Results with Key Approvals
PremiumCompany Announcements
Novartis Reports Strong Q3 2025 Results with Key Approvals
21d ago
6K
NVS
Novartis announces expiration of Tourmaline Bio tender offer
PremiumThe Fly
Novartis announces expiration of Tourmaline Bio tender offer
21d ago
NVS
TRML
Novartis price target raised to CHF 108 from CHF 105 at Morgan Stanley
PremiumThe Fly
Novartis price target raised to CHF 108 from CHF 105 at Morgan Stanley
22d ago
NVS
Midday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations
PremiumThe FlyMidday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations
22d ago
C
NP
Video: Merger Monday with deals announced in biotechnology and banking
Premium
The Fly
Video: Merger Monday with deals announced in biotechnology and banking
22d ago
AWK
DYN
Avidity acquisition has positive read for Dyne Therapeutics, says Morgan Stanley
Premium
The Fly
Avidity acquisition has positive read for Dyne Therapeutics, says Morgan Stanley
22d ago
DYN
NVS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >